首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiven
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiven
admin
2012-05-18
39
问题
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiveness have been demonstrated and of which the Food and Drug Administration (FDA) has approved, or so-called "approved uses". Other uses have come to be called "unapproved uses" and cannot be legally promoted. In a real sense, the term "unapproved" is a misnomer because it includes in one phrase two categories of marketed drugs that are very different; drugs which are potentially harmful and will never be approved, and already approved drugs that have "unapproved" uses. It is common for new research and new insights to demonstrate valid new uses for drugs already on the market. Also, there are numerous examples of medical progress resulting from the serendipitous observations and therapeutic innovations of physicians, both important methods of discovery in the field of therapeutics. Before such advances can result in new indications for inclusion in drug labeling, however, the available data must meet the legal standard of substantial evidence derived from adequate and well-controlled clinical trials. Such evidence may require time to develop, and, without initiative on the part of the drug firm, it may not occur at all for certain uses. However, because medical literature on new uses exists and these uses are medically beneficial, physicians often use these drugs for such purposes prior to FDA review or changes in labeling. This is referred to as "unlabeled uses" of drugs.
A different problem arises when a particular use for a drug has been examined scientifically and has been found to be ineffective or unsafe, and yet physicians who either are uninformed or who refuse to accept the available scientific evidence continue to use the drug in this way. Such use may have been reviewed by the FDA and rejected, or, in some cases, the use may actually be warned against in the labeling. This subset of uses may be properly termed "disapproved uses."
Government policy should minimize the extent of unlabeled uses. If such uses are valid? and many are? it is important that scientifically sound evidence supporting them be generated and that the regulatory system accommodate them into drug labeling. Continuing rapid advances in medical care and the complexity of drug usage, however, makes it impossible for the government to keep drug labeling up to date for every conceivable situation. Thus, when a particular use of this type appears, it is also important, and in the interest of good medical care, that no stigma be attached to "unapproved usage" by practitioners while the formal evidence is assembled between the time of discovery and the time the new use is included in the labeling. In the case of "disapproved uses," however, it is proper policy to warn against these in the package insert, whether use of a drug for these purposes by the uninformed or intransigent physician constitutes a violation of the current Federal Food, Drug and Cosmetic Act is a matter of debate that involves a number of technical and legal issues. Regardless of that, the inclusion of disapproved uses in the form of contraindications, warnings and other precautionary statements in package inserts is an important practical deterrent to improper use. Except for clearly disapproved uses, however, it is in the best interests of patient care that physicians not be constrained by regulatory statutes from exercising their best judgment in prescribing a drug for both its approved uses and any unlabeled uses it may have.
All of the following are mentioned in the passage as reasons for allowing unlabeled uses of drugs EXCEPT
选项
A、the increased cost to the patient of buying an FDA-approved drug
B、the medical benefits which can accrue to the patient through unlabeled use
C、the time lag between initial discovery of a medical use and FDA approval of that use
D、the possibility that a medically beneficial use may never be clinically documented
答案
A
解析
细节判断题。此题可通过排除法得出结论。因为unlabeled use的好处在首尾两段都特别强调提出,因此B是错误的。C是错误的,在第一段中提到时间滞后造成药品的新用途无法及时得到肯定。第一段中提到制造商有可能未曾知道药品的其他疗效,因此D也是错误的。A是正确答案,因为课文中找不到费用是消费者要考虑的一个内容。
转载请注明原文地址:https://kaotiyun.com/show/fAiO777K
0
专业英语八级
相关试题推荐
Science,inpractice,dependsfarlessontheexperimentsitpreparesthanonthepreparednessofthemindsofthemenwhowatch
Science,inpractice,dependsfarlessontheexperimentsitpreparesthanonthepreparednessofthemindsofthemenwhowatch
A、requiregoodeducationB、aresecondarytoeducationC、don’tcallforgoodeducationD、don’tconflictwitheducationC
Sinceancienttimesithasbeenknownthatyourwordisacausesetinmotion.Infact,theuniverseitselfisclaimedtohavee
Aspeopleage,theircellsbecomelessefficientandlessablereplacedamagedcomponents.Atthesametimetheirtissuesstiffe
Artneedsasuper-richeliteinordertoflourish,accordingtoprofessorofEnglishatLondonUniversity,LisaJardine.Jardine
Itisoftenclaimedthatnuclearenergyissomethingwecannotdowithout.Weliveinaconsumersocietywherethereisanenorm
Betweenabout1920to1930,newartistic【M1】______movementsinEuropeanartweremakingthemselvesfeltintheUnitedState
Accordingtothepassage,mostIcelandersviewlandassomethingof______.The4thparagraphinthepassage______.
TheEnglishVocabularyVocabularyisacompleteinventoryofthewordsinalanguage.Itcanbedividedintoactivevocabulary
随机试题
静脉也称容量血管,整个静脉系统可容纳全身循环血量的
A.CD2、CD3、CD4、CD7、CD8阳性B.CD10、CD19、CD20阳性C.CD16、CD56阳性D.CD13、CD14、CD15阳性B细胞及其肿瘤的表型特征是
A.肾上腺素B.利多卡因C.阿托品D.碳酸氢钠E.洛贝林用于兴奋呼吸中枢的药物是
应激源的分类有
患者男,50岁。2年前患有肝炎,入院治疗后好转,近来出现浑身乏力,食欲不振,体重减轻等症状,因而再次入院。体检:巩膜黄染,慢性肝病面容,肝肋下2cm,脾肋下刚刚触及。实验室检查:HBsAg、HBeAg、抗HBcIgM及抗核抗体均阳性。下列有关该病的说法正确
A.血虚发热B.瘀血发热C.气虚发热D.肝郁发热E.阴虚发热午后或夜间发热,手足心热或潮热,心烦,少寐多梦,颧红面赤,便干尿赤,内伤发热证属
阿托品中毒的表现有
昨天是小红的生日,后天是小伟的生日。他俩的生日距星期天同样远。如果上述断定为真,那么,今天是星期几?()
数字图像的文件格式有多种,不同的文件格式采用不同的编码方法,具有不同的特点,适合不同的应用。其中【43】图像文件格式颜色数目较少(不超过256色),文件特别小,支持动画,适合互联网传输。【44】图像文件格式是静止图像数据压缩编码的国际标准,它在数码相机和互
数据库设计过程不包括
最新回复
(
0
)